Medina-Catalan, D, Riera, P, Pages-Puigdemont, N, Masip, M, Lopez-Ferrer, A, Vilarrasa, E, Puig, L. A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence. International Journal of Clinical Pharmacy. 2022; 44(3)DOI:10.1007/s11096-022-01400-z. PMID:35380392. IF:2.400(Q3/8D).

de Bruin-Weller, MS, Serra-Baldrich, E, Barbarot, S, Grond, S, Schuster, C, Petto, H, Capron, JP, Raibouaa, A, Werfel, T. Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 2022; 12(6)DOI:10.1007/s13555-022-00734-w. PMID:35543919. IF:3.400(Q2/3D).

Carrascosa, JM, Puig, L, Romero, IB, Salgado-Boquete, L, del Alcazar, E, Lencina, JJA, Moreno, D, de la Cueva, P. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2-Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermo-Sifiliograficas. 2022; 113(6)DOI:10.1016/j.ad.2022.01.024. PMID:35748004. IF:(Q/D).

Fuchs, TL, Maclean, F, Turchini, J, Vargas, AC, Bhattarai, S, Agaimy, A, Hartmann, A, Kao, CS, Ellis, C, Bonert, M, Leroy, X, Kunju, LP, Schwartz, L, Matsika, A, Williamson, SR, Rao, P, Divatia, M, Guarch, R, Algaba, F, Balancin, ML, Zhou, M, Samaratunga, H, da Cunha, IW, Brimo, F, Ryan, A, Clouston, D, Aron, M, O'Donnell, M, Chan, E, Hirsch, MS, Moch, H, Pang, CY, Wah, C, Yin, WH, Perry-Keene, J, Yilmaz, A, Chou, A, Clarkson, A, van der Westhuizen, G, Morrison, E, Zwi, J, Hes, O, Trpkov, K, Gill, AJ. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. MODERN PATHOLOGY. 2022; 35(6)DOI:10.1038/s41379-021-00998-1. PMID:34949766. IF:7.500(Q1/1D).